ASTRAZENECA ANNOUNCES $100 MILLION INVESTMENT TO BATTLE CANCER IN CHINA

The prime focus of the research and development programme, which AstraZeneca said would focus on the benefit and value of innovative medicines for Chinese patients, will be the establishment of an innovation centre China. Initially, it will concentrate on oncology research.

The Manufacturer (http://www.themanufacturer.com/uk/detail.html?contents_id=6636)